Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study

OBJECTIVE: The combination of gemcitabine plus nab-paclitaxel (GnP) has not been studied in Japanese patients with resectable pancreatic cancer (PC). This study aimed to assess the tolerability of adjuvant GnP in Japanese patients with resected PC. METHODS: This was a Phase I, open-label, multicente...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pancreas
Main Authors: Ueno, Makoto, Morinaga, Soichiro, Hashimoto, Yusuke, Umemoto, Kumiko, Sasahira, Naoki, Saiura, Akio, Seyama, Yasuji, Honda, Goro, Ioka, Tatsuya, Takahashi, Hidenori, Miyamoto, Atsushi, Nakamori, Shoji, Unno, Michiaki, Takadate, Tatsuyuki, Mizuno, Nobumasa, Shimizu, Yasuhiro, Ueno, Hideki, Sugiyama, Masanori, Fukutomi, Akira, Shimizu, Satoshi, Okusaka, Takuji, Furuse, Junji
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748052/
https://ncbi.nlm.nih.gov/pubmed/33370027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001702
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados